Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
- 14 July 2005
- Vol. 23 (32) , 4158-4166
- https://doi.org/10.1016/j.vaccine.2005.03.017
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virusThe Esophagus, 2003
- Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization ProgramThe Journal of Infectious Diseases, 2000
- Hepatitis B Vaccination in High‐Risk Infants: 10‐Year Follow‐UpThe Journal of Infectious Diseases, 1999
- Long–Term Response to Hepatitis B Vaccination and Response to Booster in Children Born to Mothers With Hepatitis B E AntigenHepatology, 1999
- Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombin`ant vaccineResearch in Virology, 1997
- Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigenThe Journal of Pediatrics, 1995
- Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies in Catalonia, SpainPharmacoEconomics, 1995
- Twelve-year follow-up study of hepatitis B immunization of Senegalese infantsJournal of Hepatology, 1994
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988